Chardan Capital Markets upgraded Regeneron Pharma (NASDAQ: REGN) from Sell to Neutral with a price target of $350.00 on recent
This article: 215 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE